Solid-state nuclear magnetic resonance study of the physical stability of electrospun drug and polymer solid solutions

Journal of Pharmaceutical Sciences

Volumn 101, Issue 6, 2012, Pages 2185-2193

  Brettmann, Blair Kathryn ^a   Myerson, Allan S ^a   Trout, Bernhardt L ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Amorphous; Formulation; Physical stability; Relaxation time; Solid solutions; Solid state NMR; Solid state stability

Indexed keywords

ALISKIREN; INDOMETACIN; POVIDONE;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ELECTROSPINNING; HUMIDITY; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE; PHASE SEPARATION; SOLID STATE NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

EID: 84859771482     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23107     Document Type: Article

References (43)

1. Rasenack N, Hartenhauer H, Müller BW. 2003. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm 254:137-145.
2. Hu J, Johnston KP, Williams III RO. 2004. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 30:233-245.
3. Stella VJ, Nti-Addae KW. 2007. Prodrug strategies to overcome poor water solubility. Adv Drug Del Rev 59:677-694.
4. Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Del Rev 59:603-616.
5. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60.
6. Bhugra C, Pikal MJ. 2007. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. J Pharm Sci 97:1329-1349.
7. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1-12.
8. Hilden LR, Morris KR. 2003. Physics of amorphous solids. J Pharm Sci 93:3-12.
9. Yu DG, Branford-White C, Shen XX, Zhang XF, Zhu LM. 2010. Solid dispersions of ketoprofen in drug-loaded electrospun nanofibers. J Dispers Sci Tech 31:902-908.
10. Verreck G, Chun I, Rosenblatt J, Peeters J, Van Dijck A, Mensch J, Noppe M, Brewster ME. 2003. Incorporation of drugs in the amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J Control Release 92:349-360.
11. Verreck G, Chun I, Peeters J, Rosenblatt J, Brewster ME. 2003. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm Res 20:810-817.
12. Tungprapa S, Jangchut I, Supaphol P. 2007. Release characteristics of four model drugs from drug-loaded electrospun cellulose acetate fiber mats. Polymer 48:5030-5041.
13. Ignatious F, Sun L, Lee CP, Baldoni J. 2010. Electrospun nanofibers in oral drug delivery. Pharm Res 27:576-588.
14. Kenawy E-F, Abdel-Hay FI, El-Newehy MH, Wnek GE. 2009. Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 113:296-302.
15. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, Wnek GE. 2002. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release 81:57-64.
16. Ramakrishna S. 2005. An introduction to electrospinning and nanofibers. Singapore: World Scientific Publishing Company.
17. Miyazaki T, Yoshioka S, Aso Y, Kojima S. 2004. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharm Sci 93:2710-2717.
18. Konno H, Taylor LS. 2006. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95:2692-2705.
19. Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 14:1691-1698.
20. Kakumanu VK, Bansal AK. 2002. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm Res 19:1873-1878.
21. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. 2001. Physical stabilization of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 12:261-269.
22. Yu DG, Shen XX, Branford-White C, White K, Zhu LM, Bligh SWA. 2009. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology 20:055104.
23. Brettmann BK, Bell E, Myerson AM, Trout BL. 2011. Solid state NMR characterization of high-loading solid solutions of API and excipients formed by electrospinning. J Pharm Sci 101:1538-1545.
24. Gordon M, Taylor JS. 1952. Ideal copolymers and the second-order transitions of synthetic rubbers. I. Non-crystalline copolymers. J Appl Chem 2:493-500.
25. Cai WZ, Schmidt-Rohr K, Egger N, Gerharz B, Spiess HW. 1993. A solid-state n.m.r. study of microphase structure and segmental dynamics of poly(styrene-b-methylphenylsiloxane) diblock copolymers. Polymer 34:267-276.
26. Newman A, Engers D, Bates S, Ivanisevic I, Kelly RC, Zografi G. 2008. Characterization of amorphous API:polymer mixtures using X-ray powder diffraction. J Pharm Sci 97:4840-4856.
27. Qian F, Huang J, Zhu Q, Haddadin R, Gawel J, Garmise R, Hussain M. 2010. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? Int J Pharm 395:232-235.
28. Ameye D, Pringels E, Foreman P, Remon JP, Adriaensens P, Storme L, Gelan J. 2005. Correlation between the molecular morphology and the biocompatibility of bioadhesive carriers prepared from spray-dried starch/Carbopol® blends. Polymer 46:2338-2345.
29. Spevácek J, Brus J, Divers T, Grohens Y. 2007. Solid-state NMR study of biodegradable starch/polycaprolactone blends. Eur Polymer J 43:1866-1875.
30. Geppi M, Guccione S, Mollica G, Pignatello R, Veracini CA. 2005. Molecular properties of ibuprofen and its solid dispersions with eudragit RL100 studied by solid-state nuclear magnetic resonance. Pharm Res 2:1544-1555.
31. 1 relaxation measurements. Mol Pharm 7:1667-1691.
32. Straka J, Schmidt P, Dybal J, Schneider B, Spevácek J. 1994. Blends of poly(ethylene oxide)/poly(methyl methacrylate). An i.r. and n.m.r. study. Polymer 36:1147-1155.
33. McBrierty VJ, Douglass DC, Kwei TK. 1978. Compatibility in blends of poly(methyl methacrylate) and poly(styrene-co-acrylonitrile). 2. An NMR study. Macromolecules 11:1265-1267.
34. Ambike AA, Mahadik KR, Paradkar A. 2004. Stability study of amorphous valdecoxib. Int J Pharm 282:151-162.
35. Van Eerdenbrugh B, Van Speybroeck M, Mols R, Houthoofd K, Martens JA, Froyen L, Humbeeck JV, Augustijns P, Van den Mooter G. 2009. Itraconazole/TPGS/Aerosil200 solid dispersions: Characterization, physical stability and in vivo performance. Eur J Pharm Sci 38:270-278.
36. Byard SJ, Jackson SL, Smail A, Bauer M, Apperley DC. 2004. Studies on the crystallinity of a pharmaceutical development drug substance. J Pharm Sci 94:1321-1335.
37. Shin YM, Hohman MM, Brenner MP, Rutledge GC. 2001. Experimental characterization of electrospinning: the electrically forced jet and instabilitites. Polymer 42:9955-9967.
38. Bennett AE, Rienstra CM, Griffiths JM, Zhen W, Lansbury Jr PT, Grifffin RG. 1998. Homonuclear radio frequency-driven recoupling in rotating solids. J Chem Phys 108:9463.
39. Fitzpatrick S, McCabe JF, Petts CR, Booth SW. 2002. Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. Int J Pharm 246:143-151.
40. Lubach JW, Xu D, Segmuller BE, Munson EJ. 2006. Investigation of the effects of pharmaceutical processing upon solid-state NMR relaxation times and implications to solid-state formulation stability. J Pharm Sci 96:777-787.
41. Oksanen CA, Zografi G. 1993. Molecular mobility in mixtures of absorbed water and solid poly(vinylpyrrolidone). Pharm Res 10:791-799.
42. Clauss J, Schmidt-Rohr K, Spiess HW. 1993. Determination of domain sizes in heterogeneous polymers by solid-state NMR. Acta Polym 44:1-17.
43. Spiegel S, Schmidt-Rohr K, Boeffel C, Spiess HW. 1993. 1H spin diffusion coefficients of highly mobile polymers. Polymer 34:4566-4569.